These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18004154)

  • 1. Seven cases of late-life depression treated with cilostazol-augmented therapy.
    Baba H; Kubota Y; Suzuki T; Arai H
    J Clin Psychopharmacol; 2007 Dec; 27(6):727-8. PubMed ID: 18004154
    [No Abstract]   [Full Text] [Related]  

  • 2. Personality traits and recovery from major depressive disorder.
    Kronström K; Salminen JK; Hietala J; Kajander J; Vahlberg T; Markkula J; Rasi-Hakala H; Karlsson H
    Nord J Psychiatry; 2011 Feb; 65(1):52-7. PubMed ID: 20500120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
    Luis Blay S
    Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
    [No Abstract]   [Full Text] [Related]  

  • 4. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitable dose and duration of fluvoxamine administration to treat depression.
    Morishita S; Arita S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):177-81. PubMed ID: 12667164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Otte C; Hinkelmann K; Moritz S; Yassouridis A; Jahn H; Wiedemann K; Kellner M
    J Psychiatr Res; 2010 Apr; 44(6):339-46. PubMed ID: 19909979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
    J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot ulceration due to arterial insufficiency: role of cilostazol.
    Zolli A
    J Wound Care; 2004 Feb; 13(2):45-7. PubMed ID: 14999987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol in the management of vascular disease.
    Dalainas I
    Int Angiol; 2007 Mar; 26(1):1-7. PubMed ID: 17353881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP; Tonnoir B; Ménard F; Galinowski A
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurring depression].
    Lôo H
    Encephale; 2005 Oct; 31 Pt 2():S19-21. PubMed ID: 16673698
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression.
    Presecki P; Mihanović M; Silić A; Vuina AL; Caratan S
    Psychiatr Danub; 2010 Jun; 22(2):360-2. PubMed ID: 20562783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
    Hwang JP; Yang CH; Tsai SJ
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
    Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension induced by regular doses of milnacipran: a case report.
    de Toledo Ferraz Alves TC; Guerra de Andrade A
    Pharmacopsychiatry; 2007 Jan; 40(1):41-2. PubMed ID: 17327962
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
    Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
    J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder.
    Hewett K; Chrzanowski W; Jokinen R; Felgentreff R; Shrivastava RK; Gee MD; Wightman DS; O'Leary MC; Millen LS; Leon MC; Briggs MA; Krishen A; Modell JG
    J Psychopharmacol; 2010 Apr; 24(4):521-9. PubMed ID: 19164492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.